Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies
Resource Type
Article
Authors
Balakrishnan, K ; Burton, T ; Cannon, J ; Collier, D ; Coughlan, C ; D'Souza, R ; Enobakhare, E ; Findlay, E ; Gardiner-Hill, C ; Gupta, P ; Helmy, J ; Helmy, C ; Hobbs, L ; Hobbs, R ; Hood, S ; Iles, R ; Kean, S ; Kwok, S ; Lacy, P ; MacIntyre, I ; Mackay, J ; Markandu, N ; Martin, U ; McCallum, L ; McCann, G ; McGinnis, A ; Melville, V ; Muir, S ; Myint, KS ; Nazir, S ; Palmer, J ; Papworth, R ; Rutkowski, K ; Saxena, M ; Schumann, A ; Soran, H ; Stanley, A ; Thom, S ; Webb, A ; White, C ; Wilson, R ; Zak, A ; Williams, Bryan ; MacDonald, Thomas M ; Morant, Steve V ; Webb, David J ; Sever, Peter ; McInnes, Gordon T ; Ford, Ian ; Cruickshank, J Kennedy ; Caulfield, Mark J ; Padmanabhan, Sandosh ; Mackenzie, Isla S ; Salsbury, Jackie ; Brown, Morris J
Source
In The Lancet Diabetes & Endocrinology June 2018 6(6):464-475
Subject
Primary Research Articles
Language
ISSN
2213-8587